Abstract

The reduction in rheumatoid arthritis was measured by the decrease in the diameter of the joint swelling expressed in percent. The Covid-19 status was obtained from the results of the PCR Swab. The results show that in general, COVID-19 volunteers with complaints of rheumatic arthritis are satisfied with nanogold injections because they reduce pain. Health in general; temperature, blood pressure and average heart rate during clinical trials within the normal ranges of healthy people. Volunteers for clinical trials during treatment were declared negative for COVID-19. It is proven that nanogold injections increase the immunity of Covid-19 volunteers with complaints of rheumatic arthritis. As for rheumatic arthritis complaints in general, all volunteers experienced a decrease. The decrease in swelling diameter of each volunteer differed from one another in the range of 20-36%. With reduced volunteers can stand straight, walk normally and no longer hurt when the joints are pressed.

Highlights

  • The use of nanogold has penetrated in various cases of disease

  • Some of the people exposed to COVID-19 have complaints of rheumatic arthritis

  • The results of the clinical trial of community volunteers exposed to COVID-19 with complaints of rheumatic arthritis are explained as follows: 1. Overall health temperature, blood pressure and heart rate were averaged during clinical trials within the normal ranges of healthy people

Read more

Summary

Introduction

The use of nanogold has penetrated in various cases of disease. Including rheumatoid arthritis. The accumulation of joint fluid and the increased volume of joint fluid cause disturbances [3] This disorder is in the form of pain and tenderness when the joint is moved. This is because the accumulated joint fluid compresses the peripheral nerves in the joint area [4]. In this COVID-19 pandemic season, attention to people with rheumatoid arthritis needs to be done. Clinical trials of nanogold injections were carried out on people exposed to COVID-19 This clinical trial aims to increase the community's immunity during the COVID-19 pandemic season. As many as 400 volunteers, 96 people with complaints of rheumatic

Methods
Findings
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call